Found: 13
Select item for more details and to access through your institution.
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17697-1
- By:
- Publication type:
- Article
Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Elacestrant demonstrates strong anti-estrogenic activity in PDX models of estrogen-receptor positive endocrine-resistant and fulvestrant-resistant breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00483-1
- By:
- Publication type:
- Article
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Loss of Kmt2c in vivo leads to EMT, mitochondrial dysfunction and improved response to lapatinib in breast cancer.
- Published in:
- Cellular & Molecular Life Sciences, 2023, v. 80, n. 4, p. 1, doi. 10.1007/s00018-023-04734-7
- By:
- Publication type:
- Article
Abiraterone shows alternate activity in models of endocrine resistant and sensitive disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Laser Bioprinting of Cells Using UV and Visible Wavelengths: A Comparative DNA Damage Study.
- Published in:
- Bioengineering (Basel), 2022, v. 9, n. 8, p. N.PAG, doi. 10.3390/bioengineering9080378
- By:
- Publication type:
- Article
Capture Hi-C identifies putative target genes at 33 breast cancer risk loci.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03411-9
- By:
- Publication type:
- Article
Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01864-y
- By:
- Publication type:
- Article
The Hemolymph Proteome of Fed and Starved <i>Drosophila</i> Larvae.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067208
- By:
- Publication type:
- Article
Correction to: Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- corrected article
Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0157397
- By:
- Publication type:
- Article